Roche aims to lead big pharma in 21st century antibiotic discovery challenge
This article was originally published in Scrip
Executive Summary
In the space of four months Roche has signed two deals with small drug discovery companies for the development of new antibiotics; an area that had become very much devoid of big pharma action in recent years.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.